LSE creators

Number of items: 31.
Care Policy and Evaluation Centre
  • Anderson, Michael, Pitchforth, Emma, Asaria, Miqdad, Brayne, Carol, Casadei, Barbara, Charlesworth, Anita, Coulter, Angela, Franklin, Bryony Dean, Donaldson, Cam & Drummond, Michael et al (2021). LSE–Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19. The Lancet, 397(10288), 1915 - 1978. https://doi.org/10.1016/S0140-6736(21)00232-4 picture_as_pdf
  • Shemilt, Ian, Mugford, Miranda, Byford, Sarah, Drummond, Michael, Eisenstein, Eric, Knapp, Martin, Mallender, Jacqueline, McDaid, David, Vale, Luke, Walker, Damian (2008). Incorporating economics evidence. In Higgins, Julian P T, Green, Sally (Eds.), Cochrane Handbook for Systematic Reviews of Interventions (pp. 449-480). Wiley-Blackwell.
  • McDaid, David, Drummond, Michael, Suhrcke, Marc (2008). How can European health systems support investment in and the implementation of population health strategies? (Health systems and policy analysis, policy brief). World Health Organization.
    • Health Policy
  • Pagkalos, Joseph, Raikou, Maria, Drummond, Michael, McGuire, Alistair, Davis, Edward (2025). The effect of bearing surface on cementless and hybrid total hip arthroplasty survival: an updated analysis of contemporary bearing data from the National Joint Registry and hospital episode statistics. Orthopaedic Proceedings, 107-B(SUPP_2), 4 - 4. https://doi.org/10.1302/1358-992x.2025.2.004
  • Anderson, Michael, Drummond, Michael, Taylor, David, Mcguire, Alistair, Carter, Paul, Mossialos, Elias (2022). Promoting innovation while controlling cost: the UK’s approach to health technology assessment. Health Policy, 126(3), 224-233. https://doi.org/10.1016/j.healthpol.2022.01.013 picture_as_pdf
  • Anderson, Michael, Pitchforth, Emma, Asaria, Miqdad, Brayne, Carol, Casadei, Barbara, Charlesworth, Anita, Coulter, Angela, Franklin, Bryony Dean, Donaldson, Cam & Drummond, Michael et al (2021). LSE–Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19. The Lancet, 397(10288), 1915 - 1978. https://doi.org/10.1016/S0140-6736(21)00232-4 picture_as_pdf
  • Kanavos, Panos, Angelis, Aris, Drummond, Michael (2019). An EU-wide approach to HTA an irrelevant development or an opportunity not to be missed? European Journal of Health Economics, 20(3), 329-332. https://doi.org/10.1007/s10198-019-01037-2
    • LSE
  • Drummond, Michael, Ciani, Oriana, Fornaro, Giulia, Jommi, Claudio, Dietrich, Eva Susanne, Espin, Jaime, Mossman, Jean, de Pouvourville, Gerard (2024). Additional file 1 of How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy? [Dataset]. figshare. https://doi.org/10.6084/m9.figshare.26589306
  • Anderson, Michael, Drummond, Michael, Taylor, David, Mcguire, Alistair, Carter, Paul, Mossialos, Elias (2022). Promoting innovation while controlling cost: the UK’s approach to health technology assessment. Health Policy, 126(3), 224-233. https://doi.org/10.1016/j.healthpol.2022.01.013 picture_as_pdf
  • Kanavos, Panos, Angelis, Aris, Drummond, Michael (2019). An EU-wide approach to HTA an irrelevant development or an opportunity not to be missed? European Journal of Health Economics, 20(3), 329-332. https://doi.org/10.1007/s10198-019-01037-2
    • LSE Health
  • Pagkalos, Joseph, Raikou, Maria, Drummond, Michael, McGuire, Alistair, Davis, Edward (2025). The effect of bearing surface on cementless and hybrid total hip arthroplasty survival: an updated analysis of contemporary bearing data from the National Joint Registry and hospital episode statistics. Orthopaedic Proceedings, 107-B(SUPP_2), 4 - 4. https://doi.org/10.1302/1358-992x.2025.2.004
  • Drummond, Michael, Ciani, Oriana, Fornaro, Giulia, Jommi, Claudio, Dietrich, Eva Susanne, Espin, Jaime, Mossman, Jean, de Pouvourville, Gerard (2023). How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy? BMC Health Services Research, 23(1). https://doi.org/10.1186/s12913-023-09494-5 picture_as_pdf
  • Anderson, Michael, Drummond, Michael, Taylor, David, Mcguire, Alistair, Carter, Paul, Mossialos, Elias (2022). Promoting innovation while controlling cost: the UK’s approach to health technology assessment. Health Policy, 126(3), 224-233. https://doi.org/10.1016/j.healthpol.2022.01.013 picture_as_pdf
  • Anderson, Michael, Pitchforth, Emma, Asaria, Miqdad, Brayne, Carol, Casadei, Barbara, Charlesworth, Anita, Coulter, Angela, Franklin, Bryony Dean, Donaldson, Cam & Drummond, Michael et al (2021). LSE–Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19. The Lancet, 397(10288), 1915 - 1978. https://doi.org/10.1016/S0140-6736(21)00232-4 picture_as_pdf
  • Kanavos, Panos, Angelis, Aris, Drummond, Michael (2019). An EU-wide approach to HTA an irrelevant development or an opportunity not to be missed? European Journal of Health Economics, 20(3), 329-332. https://doi.org/10.1007/s10198-019-01037-2
  • Wilkinson, Grahame, Drummond, Michael (2014). Impact of reimbursement policies on the adoption of medical devices in an outpatient setting. Health Policy and Technology, 3(4), 281-286. https://doi.org/10.1016/j.hlpt.2014.08.006
  • Sorenson, Corinna, Drummond, Michael, Wilkinson, Grahame (2013). Use of innovation payments to encourage the adoption of new medical technologies in the English NHS. Health Policy and Technology, 2(3), 168-173. https://doi.org/10.1016/j.hlpt.2013.05.001
  • Sorenson, Corinna, Drummond, Michael, Bhuiyan Kahn, Beena (2013). Medical technology as a key driver of rising health expenditures: disentangling the relationship. Clinicoeconomics and Outcomes Research, 2013(5), 223-234. https://doi.org/10.2147/CEOR.S39634
  • Sorenson, Corinna, Drummond, Michael, Burns, Lawton R. (2013). Evolving reimbursement and pricing policies for devices in Europe and the United States should encourage greater value. Health Affairs, 32(4), 788-796. https://doi.org/10.1377/hlthaff.2012.1210
  • Towse, A, Drummond, Michael, Sorenson, Corinna (2012). Measuring value: pharmacoeconomics theory and practice. In Danzon, Patricia M., Nicholson, Sean (Eds.), Oxford Handbook on the Economics of the Biopharmaceutical Industry (pp. 394-437). Oxford University Press.
  • Towse, Adrian, Drummond, Michael, Sorenson, Corinna (2011). Measuring value: pharmacoeconomics in theory and practice. (Occasional paper 11/03). Office of Health Economics (London, England).
  • Sorenson, Corinna, Tarricone, Rosanna, Siebert, Markus, Drummond, Michael (2011). Applying health economics for policy decision making: how much do devices differ from drugs? Europace, 13, 1154-1158. https://doi.org/10.1093/europace/eur089
  • Drummond, Michael, Sorenson, Corinna (2009). Use of pharmacoeconomics in drug reimbursement in Australia, Canada and the UK: what can we learn from international experience? In Arnold, Renee J. G. (Ed.), Pharmacoeconomics: From Theory to Practice (pp. 175-196). CRC Press.
  • Drummond, Michael, Sorenson, Corinna (2009). Nasty or nice?: a perspective on the use of health technology assessment in the United Kingdom. Value in Health, 12(S2), S8-S13. https://doi.org/10.1111/j.1524-4733.2009.00552.x
  • Drummond, Michael, Sorenson, Corinna (2009). Can NICE be nicer?: in a world of budget constraints there are no easy solutions. Value in Health, 12(5), 634-636. https://doi.org/10.1111/j.1524-4733.2009.00540.x
  • Drummond, Michael, Brixner, Diana, Gold, Marthe, Kind, Paul, McGuire, Alistair, Nord, Erik (2009). Toward a consensus on the QALY. Value in Health, 12(Sup S1), S31-S35. https://doi.org/10.1111/j.1524-4733.2009.00522.x
  • Sorenson, Corinna, Drummond, Michael, Kanavos, Panos, McGuire, Alistair (2008). Does the work of the National Institute for Health and Clinical Excellence (NICE) have any relevance for the United States? ISPOR Connections, 14(4), 7-9.
  • Sorenson, Corinna, Drummond, Michael, Kanavos, Panos, McGuire, Alistair (2008). National Institute for Health and Clinical Excellence (NICE). How does it work and what are the implications for the U.S? National Pharmaceutical Council.
  • Sorenson, Corinna, Drummond, Michael, Kristensen, Finn Børlum, Busse, Reinhard (2008). How can the impact of health technology assessments be enhanced? (Health systems and policy analysis). World Health Organization.
  • Sorenson, Corinna, Drummond, Michael, Kanavos, Panos (2007-02-07 - 2007-02-08) Ensuring value for money in health care: The role of HTA in the European Union [Paper]. Financing sustainable healthcare in Europe: New approaches for new outcomes, Helsinki, Finland, FIN.
  • McGuire, Alistair, Drummond, Michael, Rutten, Frans (2004). Reimbursement of pharmaceuticals in the European Union. In Mossialos, Elias, Mrazek, Monique F., Walley, Tom (Eds.), Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity, and Quality (pp. 130-143). Open University.
  • McGuire, Alistair, Drummond, Michael (Eds.) (2001). Economic evaluation in health care: merging theory with practice. Oxford University Press.
  • McGuire, Alistair, Drummond, Michael, Heyse, Joseph, Cook, John (1993). Selection of end points in economic evaluations of coronary heart disease interventions. Medical Decision Making, 13(3), 184-190. https://doi.org/10.1177/0272989X9301300303
  • McGuire, Alistair, Drummond, Michael, Black, N., Pettigrew, M., McPherson, K. (1993). The economic burden of treated benign prostatic hyperplasia in the UK. British Journal of Urology, 71(3), 290-296. https://doi.org/10.1111/j.1464-410X.1993.tb15945.x
  • McGuire, Alistair, Drummond, Michael (1993). Economic evaluation in health care: an introduction for psychiatrists. Social Psychiatry and Psychiatric Epidemiology, 28(5), 211-217. https://doi.org/10.1007/BF00788739
  • McGuire, Alistair, Cook, John, Drummond, Michael, Heyse, Joseph (1993). Selection of end points in economic evaluations of coronary heart disease interventions: application to Canadian data. Canadian Journal of Cardiology, Supple, 30D-31D.
  • McGuire, Alistair, Drummond, Michael (1990). The cost-effectiveness of lipid-lowering drugs. In Lewis, Barry, Assmann, Gerd (Eds.), The Social and Economic Contexts of Coronary Prevention . Current Medical Literature Ltd.
    • Management
  • Sorenson, Corinna, Drummond, Michael (2014). Improving medical device regulation: the United States and Europe in perspective. The Milbank Quarterly, 92(1), 114-150. https://doi.org/10.1111/1468-0009.12043
    • Social Policy
  • Drummond, Michael, Brixner, Diana, Gold, Marthe, Kind, Paul, McGuire, Alistair, Nord, Erik (2009). Toward a consensus on the QALY. Value in Health, 12(Sup S1), S31-S35. https://doi.org/10.1111/j.1524-4733.2009.00522.x
  • Shemilt, Ian, Mugford, Miranda, Byford, Sarah, Drummond, Michael, Eisenstein, Eric, Knapp, Martin, Mallender, Jacqueline, McDaid, David, Vale, Luke, Walker, Damian (2008). Incorporating economics evidence. In Higgins, Julian P T, Green, Sally (Eds.), Cochrane Handbook for Systematic Reviews of Interventions (pp. 449-480). Wiley-Blackwell.
  • McGuire, Alistair, Drummond, Michael, Rutten, Frans (2004). Reimbursement of pharmaceuticals in the European Union. In Mossialos, Elias, Mrazek, Monique F., Walley, Tom (Eds.), Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity, and Quality (pp. 130-143). Open University.
  • McGuire, Alistair, Drummond, Michael (Eds.) (2001). Economic evaluation in health care: merging theory with practice. Oxford University Press.
  • McGuire, Alistair, Drummond, Michael, Heyse, Joseph, Cook, John (1993). Selection of end points in economic evaluations of coronary heart disease interventions. Medical Decision Making, 13(3), 184-190. https://doi.org/10.1177/0272989X9301300303
  • McGuire, Alistair, Drummond, Michael, Black, N., Pettigrew, M., McPherson, K. (1993). The economic burden of treated benign prostatic hyperplasia in the UK. British Journal of Urology, 71(3), 290-296. https://doi.org/10.1111/j.1464-410X.1993.tb15945.x
  • McGuire, Alistair, Drummond, Michael (1993). Economic evaluation in health care: an introduction for psychiatrists. Social Psychiatry and Psychiatric Epidemiology, 28(5), 211-217. https://doi.org/10.1007/BF00788739
  • McGuire, Alistair, Cook, John, Drummond, Michael, Heyse, Joseph (1993). Selection of end points in economic evaluations of coronary heart disease interventions: application to Canadian data. Canadian Journal of Cardiology, Supple, 30D-31D.
  • McGuire, Alistair, Drummond, Michael (1990). The cost-effectiveness of lipid-lowering drugs. In Lewis, Barry, Assmann, Gerd (Eds.), The Social and Economic Contexts of Coronary Prevention . Current Medical Literature Ltd.